Understanding BTBD17: A Potential Drug Target and Biomarker (G388419)

Target Name: BTBD17

NCBI ID: G388419

BTBD17

Understanding BTBD17: A Potential Drug Target and Biomarker

BTBD17, also known as BTB/POZ domain-containing protein 17, is a protein that is expressed in a variety of tissues and cells in the human body. It is characterized by the presence of a BTB/POZ domain, which is a protein-coding region that is found in many different proteins. The BTB/POZ domain is responsible for the protein's ability to interact with other proteins and for its role in various cellular processes.

One of the things that makes BTBD17 an interesting potential drug target is its involvement in the regulation of cell growth and differentiation. The BTB/POZ domain is known to play a role in the regulation of cell-cell adhesion, which is the process by which cells stick together and form tissues. This is important for the development and maintenance of tissues and organs, and it is also involved in the regulation of cancer.

In addition to its role in cell-cell adhesion, BTBD17 is also involved in the regulation of cell survival. The BTB/POZ domain is known to play a role in the inhibition of cell death, which is important for the survival of cells and the formation of tissues. This is important for the development and maintenance of tissues and organs, and it is also involved in the regulation of cancer.

Another potential drug target for BTBD17 is its role in the regulation of inflammation. The BTB/POZ domain is known to play a role in the regulation of inflammation and the immune response. This is important for the development and maintenance of tissues and organs, and it is also involved in the regulation of cancer.

BTBD17 is also potential biomarker for some diseases, such as cancer, where the expression of BTBD17 is often increased. This could be used as a diagnostic tool and also as a target for cancer therapy.

In conclusion, BTBD17 is a protein that is characterized by the presence of a BTB/POZ domain, which is a protein-coding region that is found in many different proteins. It is involved in the regulation of cell growth and differentiation, cell survival, and inflammation. As a result, BTBD17 is an interesting potential drug target and a biomarker for some diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: BTB Domain Containing 17

The "BTBD17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BTBD17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets